De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms

Archive ouverte

Jansen, Sandra | van der Werf, Ilse | Innes, a Micheil | Afenjar, Alexandra | Agrawal, Pankaj | Anderson, Ilse | Atwal, Paldeep | van Binsbergen, Ellen | van den Boogaard, Marie-José | Castiglia, Lucia | Coban-Akdemir, Zeynep | van Dijck, Anke | Doummar, Diane | van Eerde, Albertien | van Essen, Anthonie | van Gassen, Koen | Guillen Sacoto, Maria | van Haelst, Mieke | Iossifov, Ivan | Jackson, Jessica | Judd, Elizabeth | Kaiwar, Charu | Keren, Boris | Klee, Eric | Klein Wassink-Ruiter, Jolien | Meuwissen, Marije | Monaghan, Kristin | de Munnik, Sonja | Nava, Caroline | Ockeloen, Charlotte | Pettinato, Rosa | Racher, Hilary | Rinne, Tuula | Romano, Corrado | Sanders, Victoria | Schnur, Rhonda | Smeets, Eric | Stegmann, Alexander | Stray-Pedersen, Asbjørg | Sweetser, David | Terhal, Paulien | Tveten, Kristian | Vannoy, Grace | de Vries, Petra | Waxler, Jessica | Willing, Marcia | Pfundt, Rolph | Veltman, Joris | Kooy, R Frank | Vissers, Lisenka | de Vries, Bert

Edité par CCSD ; Nature Publishing Group -

International audience. Determining pathogenicity of genomic variation identified by next-generation sequencing techniques can be supported by recurrent disruptive variants in the same gene in phenotypically similar individuals. However, interpretation of novel variants in a specific gene in individuals with mild-moderate intellectual disability (ID) without recognizable syndromic features can be challenging and reverse phenotyping is often required. We describe 24 individuals with a de novo disease-causing variant in, or partial deletion of, the F-box only protein 11 gene (FBXO11, also known as VIT1 and PRMT9). FBXO11 is part of the SCF (SKP1-cullin-F-box) complex, a multi-protein E3 ubiquitin-ligase complex catalyzing the ubiquitination of proteins destined for proteasomal degradation. Twenty-two variants were identified by next-generation sequencing, comprising 2 in-frame deletions, 11 missense variants, 1 canonical splice site variant, and 8 nonsense or frameshift variants leading to a truncated protein or degraded transcript. The remaining two variants were identified by array-comparative genomic hybridization and consisted of a partial deletion of FBXO11. All individuals had borderline to severe ID and behavioral problems (autism spectrum disorder, attention-deficit/hyperactivity disorder, anxiety, aggression) were observed in most of them. The most relevant common facial features included a thin upper lip and a broad prominent space between the paramedian peaks of the upper lip. Other features were hypotonia and hyperlaxity of the joints. We show that de novo variants in FBXO11 cause a syndromic form of ID. The current series show the power of reverse phenotyping in the interpretation of novel genetic variances in individuals who initially did not appear to have a clear recognizable phenotype.

Consulter en ligne

Suggestions

Du même auteur

CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language

Archive ouverte | Snijders Blok, Lot | CCSD

International audience. Chromatin remodeling is of crucial importance during brain development. Pathogenic alterations of several chromatin remodeling ATPases have been implicated in neurodevelopmental disorders. We...

A genotype-first approach identifies an intellectual disability-overweight syndrome caused by PHIP haploinsufficiency

Archive ouverte | Jansen, Sandra | CCSD

International audience. Genotype-first combined with reverse phenotyping has shown to be a powerful tool in human genetics, especially in the era of next generation sequencing. This combines the identification of in...

Widening of the genetic and clinical spectrum of Lamb–Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

Archive ouverte | Zawerton, Ash | CCSD

International audience

Chargement des enrichissements...